Newly onset cytopenias not always indicate a relapsing AML after allogeneic HSCT, a case of non-destructive post transplant lymphoproliferative disorder

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains an effective option for the treatment of intermediate and high-risk Acute myeloid leukemia (AML). Post-transplant lymphoproliferative disorder (PTLD) is related to the intensity of post-transplant immunosuppression. Although Epst...

Descripción completa

Detalles Bibliográficos
Autores principales: Yiğit Kaya, Süreyya, Askin, Abdullah Emre, Bektas, Sebnem, Çakır, Aslı, Gökmen Sevindik, Ömür
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195982/
https://www.ncbi.nlm.nih.gov/pubmed/37213444
http://dx.doi.org/10.1016/j.lrr.2023.100369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195982/
https://www.ncbi.nlm.nih.gov/pubmed/37213444
http://dx.doi.org/10.1016/j.lrr.2023.100369

Ejemplares similares